Riskpilot← Back to searchSign inGet full accessRMFysio AB
ABActiveOrg 5591068399Eric Perssons Väg 5Physiotherapy activities · NACE 8695Est. 20171 employees
Revenue 2025
SEK 1,7M
-30% vs 2024
EBITDA margin
24.4%
-65% vs 2024
Equity ratio
75.7%
Financial strength
Net profit 2025
SEK 252K
-70% vs 2024
| Revenue | SEK 1,7M | -30% |
| EBITDA | SEK 409K | -65% |
| Net profit | SEK 252K | -70% |
| Total assets | SEK 1,6M | +3% |
| Equity | SEK 1,2M | -6% |
| Employees | 1 | — |
Legal name
RMFysio AB
Org number
5591068399
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
29 mars 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ämnas bedriva sjukgymnastik och därmed förenlig verksamhet jämtemot privatpersoner och företag. Verksamheten innefattar all typ av sjukgymnastisk undersökning, behandling samt rehabilitering och träning.
Address
Eric Perssons Väg 5
Email
roem.muftee@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 265 | 1 536 | 1 968 | 2 405 | 1 674 |
| Staff expenses | — | — | −1 008 | −978 | −733 |
| EBITDA | 420 | 518 | 743 | 1 156 | 409 |
| Depreciation & amort. | −15 | −87 | −87 | −87 | −87 |
| EBIT | 405 | 431 | 656 | 1 069 | 322 |
| Net financials | — | — | −0 | −1 | −2 |
| Profit before tax | 405 | 431 | 655 | 1 068 | 319 |
| Tax | −87 | −89 | −136 | −220 | −67 |
| Net profit | 318 | 342 | 520 | 848 | 252 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 734 | 920 | 979 | 1 549 | 1 602 |
| Equity | 446 | 788 | 808 | 1 285 | 1 213 |
| Long-term debt | 200 | 0 | — | 0 | — |
| Short-term debt | 88 | 132 | 172 | 264 | 389 |
| Total debt | 288 | 132 | 172 | 264 | 389 |
EBITDA margin
24.4%
This company
15.8%
Market median
+54% vs market
20212025
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
15.1%
This company
8.1%
Market median
+86% vs market
20212025
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RM Chief Executive Officer | Chief Executive Officer | 2022 |
RM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RMFysio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roem Muftee | Chief Executive Officer | 0 companies |
| Raheb Muftee | Deputy Chief Executive Officer | 0 companies |